Huahai Pharmaceutical Gets U.S. FDA Nod For Irbesartan Tablets
This article was originally published in PharmAsia News
Executive Summary
Huahai Pharmaceutical said it has won U.S. FDA approval for its generic irbesartan (Avapro) hydrochlorothiazide tablets under an Abbreviated New Drug Application to sell the products in the U.S. market.